
Amdocs Limited (NASDAQ:DOX – Free Report) – Zacks Research lifted their Q1 2027 earnings estimates for Amdocs in a report issued on Tuesday, June 2nd. Zacks Research analyst Team now anticipates that the technology company will post earnings per share of $1.70 for the quarter, up from their prior forecast of $1.69. The consensus estimate for Amdocs’ current full-year earnings is $6.54 per share. Zacks Research also issued estimates for Amdocs’ Q2 2027 earnings at $1.70 EPS.
Amdocs (NASDAQ:DOX – Get Free Report) last released its quarterly earnings results on Thursday, May 14th. The technology company reported $1.78 earnings per share for the quarter, beating analysts’ consensus estimates of $1.77 by $0.01. Amdocs had a net margin of 11.81% and a return on equity of 19.77%. The company had revenue of $1.17 billion for the quarter, compared to analyst estimates of $1.17 billion. During the same period last year, the firm earned $1.78 earnings per share. The firm’s revenue was up 3.9% on a year-over-year basis.
Check Out Our Latest Analysis on DOX
Amdocs Stock Performance
NASDAQ DOX opened at $60.84 on Thursday. Amdocs has a 52-week low of $59.40 and a 52-week high of $95.41. The company has a 50-day simple moving average of $64.14 and a 200 day simple moving average of $71.59. The company has a debt-to-equity ratio of 0.23, a quick ratio of 0.98 and a current ratio of 0.98. The company has a market capitalization of $6.57 billion, a PE ratio of 12.17, a price-to-earnings-growth ratio of 1.10 and a beta of 0.38.
Hedge Funds Weigh In On Amdocs
Several large investors have recently modified their holdings of DOX. WealthCollab LLC increased its stake in shares of Amdocs by 94.5% in the third quarter. WealthCollab LLC now owns 356 shares of the technology company’s stock worth $29,000 after purchasing an additional 173 shares in the last quarter. Atlantic Union Bankshares Corp purchased a new position in shares of Amdocs in the third quarter worth about $37,000. BOK Financial Private Wealth Inc. purchased a new position in shares of Amdocs in the fourth quarter worth about $37,000. Abich Financial Wealth Management LLC purchased a new position in shares of Amdocs in the third quarter worth about $39,000. Finally, Los Angeles Capital Management LLC purchased a new position in shares of Amdocs in the fourth quarter worth about $39,000. Hedge funds and other institutional investors own 92.02% of the company’s stock.
Amdocs Dividend Announcement
The firm also recently announced a quarterly dividend, which will be paid on Friday, July 31st. Stockholders of record on Tuesday, June 30th will be paid a $0.569 dividend. The ex-dividend date is Tuesday, June 30th. This represents a $2.28 annualized dividend and a dividend yield of 3.7%. Amdocs’s dividend payout ratio (DPR) is presently 45.60%.
About Amdocs
Amdocs (NASDAQ: DOX) is a global software and services provider specializing in solutions for communications, media and entertainment companies. The company designs, develops and integrates revenue management, customer experience and digital services platforms that enable service providers to launch and monetize new offerings, streamline operations and enhance subscriber engagement. Amdocs’ product suite encompasses billing and order management, customer relationship management, digital commerce and network function virtualization, supported by professional services for implementation, integration and managed operations.
Founded in 1982 and structured as a separate public company in 1998, Amdocs has its corporate headquarters in Chesterfield, Missouri, and maintains major development centers in Ra’anana, Israel.
Recommended Stories
- Five stocks we like better than Amdocs
- Coke’s $10B India IPO Plan Pops the Top on Hidden Value
- FedEx Unboxes Billions in Post-Spinoff Value
- Marvell’s AI Moment Raises a Bigger Question for Amazon and ServiceNow
- Palo Alto Networks Accelerates Growth 31% on AI Demand
Receive News & Ratings for Amdocs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amdocs and related companies with MarketBeat.com's FREE daily email newsletter.
